An Uncontrolled, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: BIOGEN IDEC LIMITED
- Phase: II
- Execution start: 08/11/2017
- End of execution: 30/04/2019
- PI: RAFAEL GALVEZ MATEOS